Oncology
Calidi Biotherapeutics Receives FDA Clearance for Innovative Cancer Treatment Trial
Biotech firm Calidi Biotherapeutics has obtained FDA approval to begin clinical trials of CLD-201, a novel stem cell-based virotherapy targeting solid tumors. The therapeutic approach combines adipose-derived stem cells with oncolytic vaccinia virus, potentially offering a breakthrough in treating challenging cancer types.
DoD Awards $876,000 Grant to Advance Lung Cancer Biomarker Research at Cedars-Sinai
The U.S. Department of Defense has provided funding to Cedars-Sinai Medical Center to support biomarker research for Kairos Pharma's experimental lung cancer treatment, focusing on identifying potential early intervention strategies for patients developing resistance to current therapies.
Global Brain Tumor Treatment Market Projected to Reach $7.15 Billion by 2035
The brain tumor treatment market is expected to experience substantial growth, driven by advances in medical technologies like immunotherapy and personalized medicine. The market's projected 7.2% compound annual growth rate signals significant potential for medical innovation and investment.
Silexion's Cancer Drug Shows Promise in Precision Oncology Market
Silexion Therapeutics demonstrates significant progress in KRAS-targeted cancer treatment with their RNAi therapeutic SIL-204, positioning the company as a notable player in the rapidly consolidating precision oncology market valued in billions.